Get startedLog in
    Picture of Zomedica logo

    ZOMDF — Zomedica Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Zomedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-16.9-18.4-17-34.5-47
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items1.866.847.0113.717.1
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1.72-1.35-3.35-0.161-1.07
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities-16.2-14.3-11.7-16-23.6
    Capital Expenditures-0.017-0.526-2.79-15.5-6.79
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items1.02-71.4-15317.124.6
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities1.01-71.9-1561.5817.9
    Financing Cash Flow Items-5.11-14.30—-0.07
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities76.72190.008—-0.07
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash61.5133-168-14.4-5.93